Dario Neri

Dario Neri

Company: Philogen & ETH Zürich

Job title: Co-CEO and CSO, Professor


Critical Parameters for the Accumulation of Antibody-Cytokine Fusions at the Site of Disease – How to Achieve Optimal Therapeutic Dose at the Tumor Site? 4:00 pm

Antibodies and antibody fragments, with disease homing properties,can be fused to many different cytokines Understanding how when suitable formats are chosen, antibody-cytokine fusions can retain the biological activity of the cytokine moiety and the targeting properties of the parental antibody Learning how if wrong formats are chosen, or if other undesired processes take place (e.g.,…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.